Cotreatment with growth hormone and gonadotropin for ovulation induction in hypogonadotropic patients: a prospective, randomized, placebo-controlled, dose-response study*†*Supported by Novo Nordisk A/S, Gentofte, Denmark.†Presented at the 10th Annual Meeting of the European Society of Human Reproduction and Embryology, Brussels, Belgium, June 25 to 29, 1994.‡Reprint requests: Zeev Shoham, M.D., Department of Obstetrics and Gynecology, Kaplan Hospital, Rehovot 76100, Israel.